Page last updated: 2024-08-25

voriconazole and Apparent Mineralocorticoid Excess Syndrome

voriconazole has been researched along with Apparent Mineralocorticoid Excess Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Huo, BN; Ji, HH; Jia, YT; Liu, Y; Song, L; Tang, XW; Zhang, N1
Greene, M; Harris, B; Kuriakose, K; Nesbitt, WJ1

Reviews

1 review(s) available for voriconazole and Apparent Mineralocorticoid Excess Syndrome

ArticleYear
Antifungal Therapy with Azoles Induced the Syndrome of Acquired Apparent Mineralocorticoid Excess: a Literature and Database Analysis.
    Antimicrobial agents and chemotherapy, 2022, 01-18, Volume: 66, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Azoles; Child; Humans; Itraconazole; Middle Aged; Mineralocorticoid Excess Syndrome, Apparent; Voriconazole; Young Adult

2022

Other Studies

1 other study(ies) available for voriconazole and Apparent Mineralocorticoid Excess Syndrome

ArticleYear
Posaconazole-Induced Pseudohyperaldosteronism.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:5

    Topics: Aged; Antifungal Agents; Heart Failure; Histoplasmosis; Humans; Hydroxysteroid Dehydrogenases; Hyperaldosteronism; Hypertension; Hypokalemia; Mineralocorticoid Excess Syndrome, Apparent; Triazoles; Voriconazole

2018